Your browser doesn't support javascript.
loading
Consensus on pharmacological treatment of obesity in Latin America.
Cappelletti, Ana María; Valenzuela Montero, Alex; Cercato, Cintia; Duque Ossman, John Jairo; Fletcher Vasquez, Pablo Enrique; García García, Juan Eduardo; Mancillas-Adame, Leonardo Guadalupe; Manrique, Herald Andrés; Ranchos Monterroso, Flor de María; Segarra, Pablo; Navas, Trina.
Afiliación
  • Cappelletti AM; Favaloro University, Buenos Aires, Argentina.
  • Valenzuela Montero A; Argentine Society of Nutrition, Buenos Aires, Argentina.
  • Cercato C; Chilean Society of Obesity, Santiago de Chile, Chile.
  • Duque Ossman JJ; Endocrinology and Metabology Service, Clinics Hospital, University of São Paulo Medical School, São Paulo, Brazil.
  • Fletcher Vasquez PE; Colombian Association of Endocrinology, Diabetes and Metabolism, Armenia, Colombia.
  • García García JE; Latinamerican Federation of Endocrinology, Panama City, Panama.
  • Mancillas-Adame LG; Salvador Zubiran National Institute of Medical Sciences and Nutrition, Tlalpan, Mexico.
  • Manrique HA; University Hospital and Medical School, Autonomous University of Nuevo León, Monterrey, Mexico.
  • Ranchos Monterroso FM; Peruvian Society of Endocrinology, Lima, Peru.
  • Segarra P; Guatemalan Association of Endocrinology, Metabolism and Nutrition, Guatemala City, Guatemala.
  • Navas T; Ecuadorian Society of Endocrinology, Quito, Ecuador.
Obes Rev ; 25(4): e13683, 2024 Apr.
Article en En | MEDLINE | ID: mdl-38123524
ABSTRACT
A panel of 10 experts in obesity from various Latin American countries held a Zoom meeting intending to reach a consensus on the use of anti-obesity medicines and make updated recommendations suitable for the Latin American population based on the available evidence. A questionnaire with 16 questions was developed using the Patient, Intervention, Comparison, Outcome (Result) methodology, which was iterated according to the modified Delphi methodology, and a consensus was reached with 80% or higher agreement. Failure to reach a consensus led to a second round of analysis with a rephrased question and the same rules for agreement. The recommendations were drafted based on the guidelines of the American College of Cardiology Foundation/American Heart Association Task Force on Practice. This panel of experts recommends drug therapy in patients with a body mass index of ≥30 or ≥27 kg/m2 plus at least one comorbidity, when lifestyle changes are not enough to achieve the weight loss objective; alternatively, lifestyle changes could be maintained while considering individual parameters. Algorithms for the use of long-term medications are suggested based on drugs that increase or decrease body weight, results, contraindications, and medications that are not recommended. The authors concluded that anti-obesity treatments should be individualized and multidisciplinary.
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Obesidad Límite: Humans Idioma: En Revista: Obes Rev Asunto de la revista: METABOLISMO Año: 2024 Tipo del documento: Article País de afiliación: Argentina Pais de publicación: Reino Unido
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Obesidad Límite: Humans Idioma: En Revista: Obes Rev Asunto de la revista: METABOLISMO Año: 2024 Tipo del documento: Article País de afiliación: Argentina Pais de publicación: Reino Unido